GABRIELL BUDOFF: Open Payments
NPI 1265911473 · OLD LYME, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,485 in 70 payments from 14 companies in 2025. Trend: 2023 $1,275 · 2024 $1,992 · 2025 $1,485
Food & beverage: $1,485
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $396 |
| ABBVIE INC. | 21 | $358 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Lundbeck LLC | 6 | $110 |
| Teva Pharmaceuticals USA, Inc. | 6 | $102 |
| Neurocrine BioSciences, Inc. | 5 | $95 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| Collegium Pharmaceutical, Inc. | 4 | $64 |
| Bausch Health US, LLC | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
Products named: REXULTI, VRAYLAR, COBENFY, INGREZZA, AUSTEDO XR, Auvelity, Jornay PM, CAPLYTA.
Industry payments across CT — which companies pay providers there.
